cardiac failure
Conditions
Interventions
Intervention group:Experimental group: On the basis of the control group, I-stage cardiac rehabilitation with IKAP mode was implemented.
I(information collection): collect basic information on the fir
K(Knowledge transfer): knowledge transfer on five prescriptions of cardiac rehabilitation
A(Attitude changes ideas): 3 days after admission-before the condition is stable and the exercise prescription can be implemented, strengthen the propaganda content
P(Practice urges action): Exercise prescription can be implemented when the condition is stable: 7-step exercise for phase I cardiac rehabilitation.
control group:Give patients routine treatment and care, including medication, diet guidance, intake control, health education, rehabilitation activities guidance, etc.
Sponsors
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for chronic heart failure as outlined in the "2024 Chinese Heart Failure Diagnosis and Treatment Guidelines" confirmed by a cardiologist; (2) Patients with stable heart failure with New York Heart Association (NYHA) functional class II-III; (3) Acute decompensated heart failure (including acute exacerbation of chronic heart failure), with stable vital signs and no contraindications to activity; (4) Conscious, with normal communication and reading ability, and no limb movement disorders; (5) Willing to participate and sign the informed consent form;
Exclusion criteria
Exclusion criteria: (1) Early acute coronary syndrome (within 2 days); (2) Malignant arrhythmia; (3) Acute heart failure (hemodynamically unstable); (4) Resting blood pressure >200/110 mmHg; (5) High-degree atrioventricular block; (6) Acute myocarditis, pericarditis, or endocarditis; (7) Symptomatic severeortic stenosis; (8) Severe hypertrophic obstructive cardiomyopathy; (9) Acute systemic disease; (10) Intracard thrombus; (11) Progressive worsening of resting dyspnea or reduced exercise tolerance in the last 3-5 days; (12) Se myocardial ischemia with low power exercise load (1.8 kg in the past 1-3 days; (18) Currently receiving intermittent or continuous dopamine treatment; (19) Systolic blood pressure drops during exercise; (20) NYHA Class IV heart function; (21) Complex ventricular arrhythmias rest or exertion; (22) Resting heart rate >=100 beats/min in the supine position; (23) Diseases that limit; (24) Severe liver and kidney dysfunction; (25) Severe lung disease (e.g., acute exacerbation of COPD, severe infection, etc. (26) In the terminal stage of other serious diseases (e.g., advanced malignant tumors).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 6-minute walking distance; | — |
Secondary
| Measure | Time frame |
|---|---|
| Brain natriuretic peptide (BNP);Minnesota Living with Heart Failure Questionnaire, MLHFQ;Self-Care Maintenance and Management Inventory;Generalized Anxiety Disorder-7;Patient Health Questionnaire-9;readmission rate;length of stay; | — |
Countries
China
Contacts
Public ContactLai Jianqing
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Outcome results
None listed